Effect of multimodal therapy in the treatment of adenocarcinoma of the esophagus and gastroesophageal junction : a population-based analysis from the German Clinical Cancer Registry Group
Langenbeck's Archives of Surgery · 29.05.2026 · 411 (1)
DOI: 10.1007/s00423-026-04066-7 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Langenbeck's Archives of Surgery, online erschienen am 29.05.2026. Verfasst von Thaer S A Abdalla und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Univesity of Luebeck, Ratzeburger Allee 160, Lübeck, 23562, Germany. thaer.abdalla@uksh.de. Hauptthemen laut MEDLINE: Adenocarcinoma, Esophageal Neoplasms, Esophagectomy, Neoadjuvant Therapy. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsmedizin Greifswald.
Abstract (Originalsprache)
Purpose
Multimodal treatment regimes combining surgery with perioperative chemotherapy and/or preoperative radiochemotherapy have become common treatment-modalities in resectable esophageal adenocarcinoma with controversial effects on oncological outcome.
Methods
This population-based analysis was derived from 24 German cancer registries from 2000 to 2018. The overall survival was compared over three time periods, 2000-2006: pre-neoadjuvant era (PRE-NEO); 2007-2012: implementation of neoadjuvant treatment (NEO); 2013-2018: neoadjuvant/multimodal treatment strategies (POST-NEO).
Results
For patients with adenocarcinoma of the esophagus (EAC) and gastroesophageal junction (GEJ), cTNM staging was documented in 9738 patients: Stage I (n=1405 (14%)), Stage II (n=1360 (14%)); Stage III (n=2680 (28%)); Stage IV (n=4293 (44%). The overall survival improved steadily over time for GEJ and EAC. Patients with Stage IV disease decreased over time in both tumor locations (GEJ: 71% PRENEO; 40% POST-NEO; EAC: 48% PRE-NEO to 34 %POST-NEO. Curative intended therapy increased over time (GEJ: 23% PRE-NEO; 50% POST-NEO; EAC: 29% PRENEO to 52% POST-NEO). In cTNM Stage II, perioperative chemotherapy and neoadjuvant radio chemotherapy followed by surgery were associated with longer overall survival in GEJ but not EAC compared to surgery alone. In Stage III, both multimodal treatment approaches were associated with longer overall survival in both EAC and GEJ patients when compared to surgery alone. Despite an obvious trend toward perioperative therapy, there was no statistical superiority between perioperative chemotherapy or neoadjuvant radiochemotherapy.
Conclusion
Multimodal therapy was independently associated with improved overall survival, particularly in patients with cTNM Stage III disease and Stage II GEJ tumors. These findings support current guideline-based treatment strategies and underscore the relevance of multimodal care in appropriately selected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Univesity of Luebeck, Ratzeburger Allee 160, Lübeck, 23562, Germany. thaer.abdalla@uksh.de.
- Department of Surgery, Univesity of Luebeck, Ratzeburger Allee 160, Lübeck, 23562, Germany.
- German Cancer Registry Group of the Society of German Tumor Centers-Network for Care, Quality and Research in Oncology (ADT), Berlin, 14057, Germany.
- Institute of Clinical Epidemiology and Biometry (ICE-B), University of Würzburg, Würzburg, 97080, Germany.
- Bavarian Cancer Registry, Bavarian Food and Health Safety Agency, Würzburg, Germany.
- Department of General-, Visceral-, Thoracic- and Pediatric Surgery, Southwest Clinic Network, Calwer Strasse 68, Böblingen, 71034, Germany.
Förderung
- Universitätsmedizin Greifswald
Zitieren
APA
Abdalla, T. S. A., Kist, M., Arify, R., Klinkhammer-Schalke, M., Zeissig, S. R., Tol, K. K., Benz, S., Schweigert, M., Litkevych, S., Abdalla, A. S. A., Zimmermann, M., Kersting, S., Baecker, J., Wellner, U. F., Keck, T., Thomaschewski, M., & Hummel, R. (2026). Effect of multimodal therapy in the treatment of adenocarcinoma of the esophagus and gastroesophageal junction : a population-based analysis from the German Clinical Cancer Registry Group. Langenbeck's Archives of Surgery, 411(1). https://doi.org/10.1007/s00423-026-04066-7
Vancouver
Abdalla TSA, Kist M, Arify R, Klinkhammer-Schalke M, Zeissig SR, Tol KK, et al. Effect of multimodal therapy in the treatment of adenocarcinoma of the esophagus and gastroesophageal junction : a population-based analysis from the German Clinical Cancer Registry Group. Langenbeck's Archives of Surgery. 2026;411(1). doi:10.1007/s00423-026-04066-7
BibTeX
@article{Abdalla2026,
author = {Abdalla, Thaer S A and Kist, Markus and Arify, Ruslan and Klinkhammer-Schalke, Monika and Zeissig, Sylke Ruth and Tol, Kees Kleihues-van and Benz, Stefan and Schweigert, Micheal and Litkevych, Stanislav and Abdalla, Ahmed S A and Zimmermann, Markus and Kersting, Stephan and Baecker, Justus and Wellner, Ulrich Friedrich and Keck, Tobias and Thomaschewski, Michael and Hummel, Richard},
title = {Effect of multimodal therapy in the treatment of adenocarcinoma of the esophagus and gastroesophageal junction : a population-based analysis from the German Clinical Cancer Registry Group},
journal = {Langenbeck's Archives of Surgery},
year = {2026},
volume = {411},
number = {1},
doi = {10.1007/s00423-026-04066-7}
}
EUVIMED